FDA is expecting one of its priority review voucher programs to potentially take off in fiscal year 2016, if not earlier.
Nearly $8 million is included in President Obama’s FY 2016 budget request for rare pediatric disease priority review voucher user fees, suggesting that several may be
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?